Literature DB >> 23318603

Pre-therapeutic dosimetry evaluation and selective internal radiation therapy of hepatocellular carcinoma using yttrium-90-loaded microspheres.

Etienne Garin, Yan Rolland, Eveline Boucher.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23318603     DOI： 10.1016/j.jhep.2012.11.050

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  5 in total

Review 1.  Management of hepatocellular carcinoma with portal vein thrombosis.

Authors:  Matthew Quirk; Yun Hwan Kim; Sammy Saab; Edward Wolfgang Lee
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

3.  Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis.

Authors:  Claus Christian Pieper; Winfried A Willinek; Daniel Thomas; Hojjat Ahmadzadehfar; Markus Essler; Jennifer Nadal; Kai E Wilhelm; Hans Heinz Schild; Carsten Meyer
Journal:  Eur Radiol       Date:  2015-11-11       Impact factor: 5.315

Review 4.  Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects.

Authors:  Philippe d'Abadie; Michel Hesse; Amandine Louppe; Renaud Lhommel; Stephan Walrand; Francois Jamar
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

5.  Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.

Authors:  E Garin; L Lenoir; J Edeline; S Laffont; H Mesbah; P Porée; L Sulpice; K Boudjema; M Mesbah; A Guillygomarc'h; E Quehen; M Pracht; J L Raoul; B Clement; Y Rolland; E Boucher
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-24       Impact factor: 9.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.